[ad_1]
The Japanese drugmaker said it agreed to acquire Iveric bio for about $5.9 billion to strengthen its capabilities in the ophthalmology field.
[ad_2]
Source link
Astellas Pharma to Buy Iveric Bio for About $5.9B
April 21, 2025
